Neoadj T-VEC May Improve Survival in Resectable Melanoma Neoadj T-VEC May Improve Survival in Resectable Melanoma

Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news